Xinmeng Jasmine Mu

Xinmeng Jasmine Mu has extensive experience in computational biology, particularly within the oncology sector. With a career spanning over nine years at Pfizer, starting as a Principal Scientist of Computational Biology and advancing to Director of Computational Biology, Xinmeng led bioinformatics initiatives across various stages of drug development, focusing on biomarkers and clinical responses in oncology. Previously, at the Broad Institute of MIT and Harvard, Xinmeng contributed to genomic studies related to immune-cell infiltration and biomarker discovery in multiple cancer types, while also collaborating with various academic and medical institutions. Xinmeng holds a Ph.D. and M.S. in Computational Biology and Bioinformatics from Yale University.